ClassID:

94333

C07D223/08 - CPC Classification

Classification description:

Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms Oxygen atoms

Sub-classes:
Recent Application in this class:
#1
20230010299
2023-01-12

HETEROCYCLIC TRPML1 AGONISTS

#2
20210009519
2021-01-14

HISTONE DEACETYLASE INHIBITORS

#3
20190382342
2019-12-19

Histone deacetylase inhibitors

#4
20190262356
2019-08-29

Heterocyclic amides as kinase inhibitors

#5
20190201413
2019-07-04

Heterocyclic amides as kinase inhibitors

#6
20190194163
2019-06-27

Dual NAV1.2/5HT2a inhibitors for treating CNS disorders

#7
20190016682
2019-01-17

Azepane derivatives and methods of treating hepatitis B infections

#8
20180370915
2018-12-27

Histone deacetylase inhibitors

#9
20180319737
2018-11-08

Phenyl-(aza)cycloalkyl carboxylic acid GPR120 modulators

#10
20180037893
2018-02-08

Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery

#11
20170327457
2017-11-16

PHENYL-(AZA)CYCLOALKYL CARBOXYLIC ACID GPR120 MODULATORS

#12
20170183332
2017-06-29

Heterocyclic amides as kinase inhibitors

#13
20170114036
2017-04-27

Process for preparing cyclic esters and cyclic amides

#14
20170015629
2017-01-19

Azepane derivatives and methods of treating hepatitis B infections

#15
20170008878
2017-01-12

Heterocyclic amides as kinase inhibitors

#16
20160208172
2016-07-21

Liquid crystal composition containing nitrogen-containing cyclic compound and liquid crystal display device

#17
20160031821
2016-02-04

SDP-containing heterobifunctional agents

#18
20150376159
2015-12-31

Process for preparing cyclic esters and cyclic amides

#19
20150361434
2015-12-17

Low molecular weight cyclic amine containing cationic lipids for oligonucleotide delivery

#20
20150225355
2015-08-13

Azepane derivatives and methods of treating hepatitis B infections

#21
20150197533
2015-07-16

Azepane derivatives and methods of treating hepatitis B infections

#22
20150197493
2015-07-16

Azepane derivatives and methods of treating hepatitis B infections

#23
20150031670
2015-01-29

Cyclic amides as MetAP-2 inhibitors

#24
20140228354
2014-08-14

Method for inhibition of deubiquitinating activity

#25
20140107323
2014-04-17

SDP-containing heterobifunctional agents

#26
20130196978
2013-08-01

Alkaloid aminoester derivatives and medicinal composition thereof

#27
20120232039
2012-09-13

Primary amine diazeniumdiolate heterocyclic derivatives

#28
20110129542
2011-06-02

SUBSTITUTED AZEPINE- AND DIAZEPINE-SULFONAMIDES USEFUL TO INHIBIT 11BETA-HYDROXYSTEROID DEHYDROGENASE TYPE-1

#29
20100234588
2010-09-16

Synthetic method for ceratamine A and B and analogs thereof

#30
20100173880
2010-07-08

Alkaloid aminoester derivatives and medicinal composition thereof

#31
20090326261
2009-12-31

Preparation of diesters from imide/dinitrile compounds

#32
20090298877
2009-12-03

Salts of creatine imino sugar amides

#33
20090297685
2009-12-03

Preparations containing creatine and imino sugars

#34
20090176859
2009-07-09

Cathepsin cysteine protease inhibitors

#35
20070021404
2007-01-25

Novel aza-ring derivatives and their use as monoamine neurotransmitter re-uptake inhibitors

#36
20060287402
2006-12-21

Cathepsin inhibitors

#37
20060194787
2006-08-31

Protease inhibitors

#38
20060160790
2006-07-20

Thioureas as factor Xa inhibitors

#39
20060052365
2006-03-09

Protease inhibitors

#40
20060009443
2006-01-12

Fused heterocyclic compounds and their use as metabotropic glutamate receptor antagonists

#41
20050038081
2005-02-17

Amidobenzamide derivatives which are useful as cytokine inhibitors

#42
20050030912
2005-02-10

Use of hybrid (HW/DSP/MCU/SW) architectures for powerline OFDM communication field